Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| XWELL, Inc.XSPA · Entity 1233 | Director | February 11, 2019 | February 13, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
XWELL, Inc.
Report date February 11, 2019 · Filed February 13, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.21 · Expires 2029-02-11 | Direct | 170,000 |
Reported balance
After 2019-02-11 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2019-02-11 · Grant · Acquired 170,000 · Balance 170,000 F1: These securities were issued as part of the Issuer's annual equity grant to directors. F2: The shares underlying this option vest in equal quarterly installments over a one-year period, with one-fourth vesting on the date of grant and one-fourth vesting at the end of each fiscal quarter, such that the options will be fully vested as of December 31, 2019. |
Filing footnotes · ownership attribution and instrument terms
F1: These securities were issued as part of the Issuer's annual equity grant to directors.
F2: The shares underlying this option vest in equal quarterly installments over a one-year period, with one-fourth vesting on the date of grant and one-fourth vesting at the end of each fiscal quarter, such that the options will be fully vested as of December 31, 2019.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 11, 2019 Filed Feb 13, 2019 21:11 UTC | XWELL, Inc. XSPA · Entity 1233 | GrantStock Option (Right to Buy) · Derivative | 170,000 | $0.00 Strike: $0.21 | $0.00 |
DisclosureSEC source: 0001144204-19-007153 · tv513325_4.xml · derivative · entry 1 GIARDINA SALVATORE · CIK 0001198079 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170,000 Underlying: Common Stock · 170,000 shares Expires 2029-02-11 F1 · security: These securities were issued as part of the Issuer's annual equity grant to directors. F1 · price: These securities were issued as part of the Issuer's annual equity grant to directors. F2 · derivative.exercise_date: The shares underlying this option vest in equal quarterly installments over a one-year period, with one-fourth vesting on the date of grant and one-fourth vesting at the end of each fiscal quarter, such that the options will be fully vested as of December 31, 2019. Read SEC document |
| January 17, 2017 Filed Jan 20, 2017 22:41 UTC | XWELL, Inc. FH · Entity 1233 | GrantStock Option · Derivative | 85,000 | $0.00 Strike: $2.12 | $0.00 |
DisclosureSEC source: 0001144204-17-003257 · v456881_4.xml · derivative · entry 1 GIARDINA SALVATORE · CIK 0001198079 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,000 Underlying: Common Stock · 85,000 shares Expires 2027-01-17 F1 · security: These securities were issued as part of the Issuer's annual equity compensation to non-employee directors. F1 · price: These securities were issued as part of the Issuer's annual equity compensation to non-employee directors. F2 · derivative.exercise_date: These options to purchase shares of common stock of the Issuer vest in equal quarterly installments over a one-year period, with one-fourth vesting on the date of grant and one-fourth vesting at the end of each fiscal quarter thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.